www.novanews.org  

Hemangioma& Vascular Malformation

Advocacy and Support

   
line decor
  HOME  :: Vascular Anomalies   :
line decor
   
 

Low Platelets and GI Bleeding Associated with Hemangioma

 

Has your child been diagnosed with “hemangiomas”, low levels of platelets, and gastrointestinal bleeding?

 

Your child could have a recently discovered disorder entitled multifocal lymphangioendotheliomatosis with thrombocytopenia (see articles). This disease has also been titled cutaneovisceral angiomatosis with thrombocytopenia in the medical literature. Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT) is a rare vascular disorder characterized by multiple red- brown skin lesions, often misdiagnosed as hemangiomas. Children with this disease have similar lesions in the stomach an intestines which tend to bleed, especially during the first year of life leading to very low blood counts. The children suffer from  profound thrombocytopenia (low platelet counts, below 30,000-50,000). Although a relatively newly described entity, MLT was and continues to be misdiagnosed as blue rubber bleb nevus syndrome, diffuse hemangiomatosis, Kasabach-Merritt phenomenon, and hereditary hemorrhagic telangiectasia.

 

The Birthmark and Vascular Anomalies Center at Children’s Hospital of Wisconsin has created an interdisciplinary task force to study infants with vascular disorders and low platelets. The task force is a collective group of clinicians and researchers from diverse pediatric specialties including; dermatology, neonatology, otolaryngology, gastroenterology, hematology/oncology, genetics and pathology. We have designed a registry to collect information on all patients with MLT. The registry will address many unanswered questions regarding risk factors and treatment options for this rare disease. Dr. Paula North, who originally described this disease, will review all biopsy specimens. This data will be used to better understand the disease, design diagnostic criteria, and create treatment guidelines. Ultimately the project will aim to obtain national funding to study the cause of MLT and generate safe and effective therapeutic interventions.

If you think your child has multifocal lymphangioendotheliomatosis with thrombocytopenia/cutaneovisceral angiomatosis with thrombocytopenia please contact us so we can learn more about this disease. This study is approved by our Internal Review Board and will send you a consent form.

Contact Information:

Linda Go, MD

Research Fellow, Pediatric Dermatology

Medical College of Wisconsin

Adress:9200 West Wisconsin Avenue

Froedert Hospital East

Department of Dermatology

Milwaukee, WI 53226

Phone: 414-266-6431            Fax: 414-266-3315

E-mail: lgo@mcw.edu

 

Beth A Drolet, M.D.

Professor of Dermatology and Pediatrics

Medical College of Wisconsin, Milwaukee Wisconsin

Medical Director of Dermatology and Birthmarks and Vascular Anomalies Children’s’ Hospital of Wisconsin

Address: 9200 West Wisconsin Avenue

Froedert Hospital East

Department of Dermatology

E-mail: drolet@mcw.edu

Phone: 414-805-5304

 


  

 

 

 

NOVA PROVIDES THIS INFORMATION TO FAMILIES AS A RESOURCE. IT IS NOT INTENDED TO ENGAGE IN THE PRACTICE OF MEDICINE OR TO REPLACE THE PHYSICIAN. NOVA DOES NOT CLAIM TO HAVE MEDICAL KNOWLEDGE. NOVA DOES NOT ENDORSE ANY PARTICULAR PHYSICIAN, TREATING FACILITY OR TREATMENT PROTOCAL. IN ALL CASES NOVA AND ITS BOARD OF DIRECTORS RECOMMENDS THAT YOU SEEK THE OPINION OF A PHYSICIAN EXPERIENCED IN THE MANAGEMENT OF HEMANGIOMAS AND VASCULAR MALFORMATIONS. 


THIS WEB SITE IS OPERATED BY THE NATIONAL ORGANIZATION OF VASCULAR ANOMALIES BOARD OF DIRECTORS.  NOVA BOARD .  CONTACT WEB MASTER AT admin@mail.novanews.org. 

 

 

Research Index

PHACES Doppler Imaging Study

Genetic Basis of PHACE:  Dwan Siegel

Registries Index

Hemangioma with low platelet levels andGI bleeding

PHACES Registry

Rare Benign Tumor Registry

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

Copyright© 2008   www.novanews.org    

lUpdated January 5, 2008

We subscribe to the Honcode principles

NOVA is a 501c3a organization all donations are tax deductible.  NOVA was originally founded as Hemangioma Newsline